202 related articles for article (PubMed ID: 29413985)
21. NMR-Guided Mass Spectrometry for Absolute Quantitation of Human Blood Metabolites.
Nagana Gowda GA; Djukovic D; Bettcher LF; Gu H; Raftery D
Anal Chem; 2018 Feb; 90(3):2001-2009. PubMed ID: 29293320
[TBL] [Abstract][Full Text] [Related]
22. NMR/MS Translator for the Enhanced Simultaneous Analysis of Metabolomics Mixtures by NMR Spectroscopy and Mass Spectrometry: Application to Human Urine.
Bingol K; Brüschweiler R
J Proteome Res; 2015 Jun; 14(6):2642-8. PubMed ID: 25881480
[TBL] [Abstract][Full Text] [Related]
23. The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research.
Emwas AH
Methods Mol Biol; 2015; 1277():161-93. PubMed ID: 25677154
[TBL] [Abstract][Full Text] [Related]
24. Accurate Identification of Unknown and Known Metabolic Mixture Components by Combining 3D NMR with Fourier Transform Ion Cyclotron Resonance Tandem Mass Spectrometry.
Wang C; He L; Li DW; Bruschweiler-Li L; Marshall AG; Brüschweiler R
J Proteome Res; 2017 Oct; 16(10):3774-3786. PubMed ID: 28795575
[TBL] [Abstract][Full Text] [Related]
25. 1H NMR-derived metabolomics of filtered serum of myocardial ischemia in unstable angina patients.
Ameta K; Gupta A; Ameta D; Sethi R; Kumar D; Ahmad I; Mahdi AA
Clin Chim Acta; 2016 May; 456():56-62. PubMed ID: 26926967
[TBL] [Abstract][Full Text] [Related]
26. Towards automatic metabolomic profiling of high-resolution one-dimensional proton NMR spectra.
Mercier P; Lewis MJ; Chang D; Baker D; Wishart DS
J Biomol NMR; 2011 Apr; 49(3-4):307-23. PubMed ID: 21360156
[TBL] [Abstract][Full Text] [Related]
27. Application of LC-MS-based metabolomics method in differentiating septic survivors from non-survivors.
Liu Z; Yin P; Amathieu R; Savarin P; Xu G
Anal Bioanal Chem; 2016 Nov; 408(27):7641-7649. PubMed ID: 27614981
[TBL] [Abstract][Full Text] [Related]
28. 15N-cholamine--a smart isotope tag for combining NMR- and MS-based metabolite profiling.
Tayyari F; Gowda GA; Gu H; Raftery D
Anal Chem; 2013 Sep; 85(18):8715-21. PubMed ID: 23930664
[TBL] [Abstract][Full Text] [Related]
29. Precision of a Clinical Metabolomics Profiling Platform for Use in the Identification of Inborn Errors of Metabolism.
Ford L; Kennedy AD; Goodman KD; Pappan KL; Evans AM; Miller LAD; Wulff JE; Wiggs BR; Lennon JJ; Elsea S; Toal DR
J Appl Lab Med; 2020 Mar; 5(2):342-356. PubMed ID: 32445384
[TBL] [Abstract][Full Text] [Related]
30. Optimization of metabolite extraction of human vein tissue for ultra performance liquid chromatography-mass spectrometry and nuclear magnetic resonance-based untargeted metabolic profiling.
Anwar MA; Vorkas PA; Li JV; Shalhoub J; Want EJ; Davies AH; Holmes E
Analyst; 2015 Nov; 140(22):7586-97. PubMed ID: 26468486
[TBL] [Abstract][Full Text] [Related]
31. New Methodology for Known Metabolite Identification in Metabonomics/Metabolomics: Topological Metabolite Identification Carbon Efficiency (tMICE).
Sanchon-Lopez B; Everett JR
J Proteome Res; 2016 Sep; 15(9):3405-19. PubMed ID: 27490438
[TBL] [Abstract][Full Text] [Related]
32. Metabolomics toward personalized medicine.
Jacob M; Lopata AL; Dasouki M; Abdel Rahman AM
Mass Spectrom Rev; 2019 May; 38(3):221-238. PubMed ID: 29073341
[TBL] [Abstract][Full Text] [Related]
33. NMR analysis of budding yeast metabolomics: a rapid method for sample preparation.
Airoldi C; Tripodi F; Guzzi C; Nicastro R; Coccetti P
Mol Biosyst; 2015 Feb; 11(2):379-83. PubMed ID: 25333203
[TBL] [Abstract][Full Text] [Related]
34. The role of the Human Metabolome Database in inborn errors of metabolism.
Mandal R; Chamot D; Wishart DS
J Inherit Metab Dis; 2018 May; 41(3):329-336. PubMed ID: 29663269
[TBL] [Abstract][Full Text] [Related]
35. Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy.
Hirayama A; Nakashima E; Sugimoto M; Akiyama S; Sato W; Maruyama S; Matsuo S; Tomita M; Yuzawa Y; Soga T
Anal Bioanal Chem; 2012 Dec; 404(10):3101-9. PubMed ID: 23052862
[TBL] [Abstract][Full Text] [Related]
36. Structural elucidation of novel biomarkers of known metabolic disorders based on multistage fragmentation mass spectra.
Václavík J; Coene KLM; Vrobel I; Najdekr L; Friedecký D; Karlíková R; Mádrová L; Petsalo A; Engelke UFH; van Wegberg A; Kluijtmans LAJ; Adam T; Wevers RA
J Inherit Metab Dis; 2018 May; 41(3):407-414. PubMed ID: 29139026
[TBL] [Abstract][Full Text] [Related]
37. Sample preparation methods for LC-MS-based global aqueous metabolite profiling.
Beltran A; Samino S; Yanes O
Methods Mol Biol; 2014; 1198():75-80. PubMed ID: 25270923
[TBL] [Abstract][Full Text] [Related]
38. A robust intracellular metabolite extraction protocol for human neutrophil metabolic profiling.
Chokesuwattanaskul S; Phelan MM; Edwards SW; Wright HL
PLoS One; 2018; 13(12):e0209270. PubMed ID: 30571714
[TBL] [Abstract][Full Text] [Related]
39. Metabolic profiling of ob/ob mouse fatty liver using HR-MAS
Gogiashvili M; Edlund K; Gianmoena K; Marchan R; Brik A; Andersson JT; Lambert J; Madjar K; Hellwig B; Rahnenführer J; Hengstler JG; Hergenröder R; Cadenas C
Anal Bioanal Chem; 2017 Feb; 409(6):1591-1606. PubMed ID: 27896396
[TBL] [Abstract][Full Text] [Related]
40. Global metabolic profiling using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Qi Y; Song Y; Gu H; Fan G; Chai Y
Methods Mol Biol; 2014; 1198():15-27. PubMed ID: 25270920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
